A similar situation was observed with mSEPT9, where SEPT9 gene methylation was detected in a significant percentage of gastric cancer, head and neck squamous carcinoma, hepatic carcinoma, esophageal cancer, lung cancer, cholangiocarcinoma, and bladder cancer patients.45, 73, 74, 75, 76. Here, SEPTIN9 is linked to urinary bladder carcinoma.